Balchem Co. (NASDAQ:BCPC) has earned an average recommendation of “Hold” from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $105.00.
Several equities research analysts recently weighed in on the company. HC Wainwright reaffirmed a “positive” rating and set a $110.00 price target (up from $95.00) on shares of Balchem in a report on Wednesday, November 6th. Zacks Investment Research lowered shares of Balchem from a “hold” rating to a “strong sell” rating in a research report on Thursday, November 7th. BidaskClub cut shares of Balchem from a “hold” rating to a “sell” rating in a research note on Thursday, November 21st. Finally, ValuEngine downgraded shares of Balchem from a “hold” rating to a “sell” rating in a research report on Wednesday, December 4th.
Large investors have recently made changes to their positions in the stock. CWM LLC purchased a new position in shares of Balchem during the 2nd quarter worth approximately $31,000. Krane Funds Advisors LLC acquired a new position in Balchem during the second quarter worth $60,000. Tower Research Capital LLC TRC purchased a new position in Balchem in the second quarter worth $65,000. First Mercantile Trust Co. purchased a new position in Balchem in the third quarter worth $72,000. Finally, HM Payson & Co. purchased a new position in Balchem in the second quarter worth $147,000. Hedge funds and other institutional investors own 88.01% of the company’s stock.
Balchem (NASDAQ:BCPC) last announced its earnings results on Tuesday, November 5th. The basic materials company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.07. The company had revenue of $158.60 million for the quarter, compared to the consensus estimate of $166.42 million. Balchem had a return on equity of 14.01% and a net margin of 12.43%. The company’s revenue was up 2.3% on a year-over-year basis. During the same period last year, the business posted $0.73 EPS. On average, research analysts anticipate that Balchem will post 3.16 EPS for the current year.
Balchem Company Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.